SHARE

Nordic Capital and Permira make $3bn bid for Danish vaccine firm Bavarian Nordic 

The PE firms have offered 233 Danish crowns per share for Bavarian Nordic, valuing the company at around $3bn. The board has recommended the bid, which offers a 21% premium and reflects continued uncertainty in the US vaccines market.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.